FDA approval of female libido pill could cause women to suffer “epidemic of adverse effects”

Share it with your friends Like

Thanks! Share it with your friends!

Close

By By David Gutierrez, staff writer

(NaturalNews) On August 18, the FDA approved a drug for the controversial condition of female hypoactive sexual desire disorder. The drug, flibanserin (to be marketed as Addyi), had previously been rejected twice by the agency due to low effectiveness combined with a high risk of…

…read more

Read more here: Natural News

    

  • Rating:
  • Views:484 views
  • Categories: Health